HEADER BIOSYNTHETIC PROTEIN 03-SEP-19 6U7X TITLE NMR SOLUTION STRUCTURE OF TRIAZOLE BRIDGED PLASMIN INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLY-ARG-ALA-TYR-LYS-SER-LYS-PRO-PRO-ILE-ALA-PHE-PRO-ASP; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HELIANTHUS ANNUUS; SOURCE 4 ORGANISM_TAXID: 4232 KEYWDS TRIAZOLE, DISULFIDE MIMETIC, INHIBITOR, BIOSYNTHETIC PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR A.M.WHITE,P.J.HARVEY,C.K.WANG,T.DUREK,D.J.CRAIK REVDAT 3 30-OCT-24 6U7X 1 LINK REVDAT 2 15-JUL-20 6U7X 1 JRNL REVDAT 1 22-APR-20 6U7X 0 JRNL AUTH A.M.WHITE,S.J.DE VEER,G.WU,P.J.HARVEY,K.YAP,G.J.KING, JRNL AUTH 2 J.E.SWEDBERG,C.K.WANG,R.H.P.LAW,T.DUREK,D.J.CRAIK JRNL TITL APPLICATION AND STRUCTURAL ANALYSIS OF TRIAZOLE-BRIDGED JRNL TITL 2 DISULFIDE MIMETICS IN CYCLIC PEPTIDES. JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 59 11273 2020 JRNL REFN ESSN 1521-3773 JRNL PMID 32270580 JRNL DOI 10.1002/ANIE.202003435 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6U7X COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-SEP-19. REMARK 100 THE DEPOSITION ID IS D_1000243614. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298; 298 REMARK 210 PH : 3.5; 3.5 REMARK 210 IONIC STRENGTH : TFA; TFA REMARK 210 PRESSURE : AMBIENT PA; AMBIENT PA REMARK 210 SAMPLE CONTENTS : 1.5 MM DR12, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H TOCSY; 2D 1H-1H NOESY; REMARK 210 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 2D 1H-1H E.COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA, CCPNMR ANALYSIS REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 13 -8.98 -57.67 REMARK 500 3 PRO A 13 -17.06 -49.18 REMARK 500 4 PRO A 13 9.33 -60.91 REMARK 500 5 PRO A 13 -7.73 -52.54 REMARK 500 7 PRO A 13 4.13 -59.57 REMARK 500 8 PRO A 13 -16.28 -49.68 REMARK 500 9 PRO A 9 92.11 -66.67 REMARK 500 10 PRO A 13 -46.22 -25.24 REMARK 500 11 PRO A 9 96.88 -63.35 REMARK 500 11 PRO A 13 -7.99 -58.36 REMARK 500 14 PRO A 13 -19.49 -46.50 REMARK 500 15 PRO A 9 95.43 -66.41 REMARK 500 18 PRO A 13 3.17 -65.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue WMH A 101 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6U24 RELATED DB: PDB REMARK 900 RELATED ID: 6U7R RELATED DB: PDB REMARK 900 RELATED ID: 6U7W RELATED DB: PDB REMARK 900 RELATED ID: 6U7S RELATED DB: PDB REMARK 900 RELATED ID: 6U7Q RELATED DB: PDB REMARK 900 RELATED ID: 6U7U RELATED DB: PDB REMARK 900 RELATED ID: 6U22 RELATED DB: PDB REMARK 900 RELATED ID: 6Q1U RELATED DB: PDB REMARK 900 RELATED ID: 30671 RELATED DB: BMRB REMARK 900 NMR SOLUTION STRUCTURE OF TRIAZOLE BRIDGED PLASMIN INHIBITOR DBREF 6U7X A 1 14 PDB 6U7X 6U7X 1 14 SEQRES 1 A 14 GLY ARG ALA TYR LYS SER LYS PRO PRO ILE ALA PHE PRO SEQRES 2 A 14 ASP HET WMH A 101 9 HETNAM WMH 1-METHYL-1H-1,2,3-TRIAZOLE FORMUL 2 WMH C3 H5 N3 SHEET 1 AA1 2 ARG A 2 ALA A 3 0 SHEET 2 AA1 2 ALA A 11 PHE A 12 -1 O PHE A 12 N ARG A 2 LINK N GLY A 1 C ASP A 14 1555 1555 1.32 LINK CB ALA A 3 C WMH A 101 1555 1555 1.52 LINK CB ALA A 11 C1 WMH A 101 1555 1555 1.53 CISPEP 1 LYS A 7 PRO A 8 1 1.38 CISPEP 2 LYS A 7 PRO A 8 2 2.11 CISPEP 3 LYS A 7 PRO A 8 3 1.63 CISPEP 4 LYS A 7 PRO A 8 4 0.53 CISPEP 5 LYS A 7 PRO A 8 5 -1.26 CISPEP 6 LYS A 7 PRO A 8 6 1.69 CISPEP 7 LYS A 7 PRO A 8 7 0.24 CISPEP 8 LYS A 7 PRO A 8 8 -4.95 CISPEP 9 LYS A 7 PRO A 8 9 0.16 CISPEP 10 LYS A 7 PRO A 8 10 -2.08 CISPEP 11 LYS A 7 PRO A 8 11 1.39 CISPEP 12 LYS A 7 PRO A 8 12 -1.69 CISPEP 13 LYS A 7 PRO A 8 13 0.41 CISPEP 14 LYS A 7 PRO A 8 14 2.76 CISPEP 15 LYS A 7 PRO A 8 15 0.47 CISPEP 16 LYS A 7 PRO A 8 16 -0.97 CISPEP 17 LYS A 7 PRO A 8 17 -3.01 CISPEP 18 LYS A 7 PRO A 8 18 2.77 CISPEP 19 LYS A 7 PRO A 8 19 -2.47 CISPEP 20 LYS A 7 PRO A 8 20 1.42 SITE 1 AC1 4 ALA A 3 PRO A 9 ILE A 10 ALA A 11 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1